0001416038-11-000002.txt : 20111017
0001416038-11-000002.hdr.sgml : 20111017
20111017115730
ACCESSION NUMBER: 0001416038-11-000002
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20111014
FILED AS OF DATE: 20111017
DATE AS OF CHANGE: 20111017
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Aragues Alain
CENTRAL INDEX KEY: 0001483588
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19119
FILM NUMBER: 111143257
MAIL ADDRESS:
STREET 1: 41 MOORES ROAD
CITY: FRAZER
STATE: PA
ZIP: 19355
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CEPHALON INC
CENTRAL INDEX KEY: 0000873364
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 232484489
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 41 MOORES ROAD
CITY: FRAZER
STATE: PA
ZIP: 19355
BUSINESS PHONE: 6103440200
MAIL ADDRESS:
STREET 1: 41 MOORES ROAD
CITY: FRAZER
STATE: PA
ZIP: 19355
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0304
4
2011-10-14
1
0000873364
CEPHALON INC
CEPH
0001483588
Aragues Alain
41 MOORES ROAD
FRAZER
PA
19355
0
1
0
0
Exec VP, President Europe
Common Stock
2011-10-14
4
D
0
42275
D
0
D
Non-Qualified Stock Option
64.62
2011-10-14
4
D
0
25000
D
2006-02-01
2012-02-01
Common Stock
25000
0
D
Non-Qualified Stock Option
48.06
2011-10-14
4
D
0
300
D
2008-12-16
2014-12-16
Common Stock
300
0
D
Non-Qualified Stock Option
51.08
2011-10-14
4
D
0
4300
D
2009-12-01
2015-12-01
Common Stock
4300
0
D
Non-Qualified Stock Option
71.07
2011-10-14
4
D
0
4300
D
2010-12-19
2016-12-19
Common Stock
4300
0
D
Non-Qualified Stock Option
76.11
2011-10-14
4
D
0
5200
D
2011-12-13
2017-12-13
Common Stock
5200
0
D
Non-Qualified Stock Option
73.25
2011-10-14
4
D
0
5200
D
2012-12-11
2018-12-11
Common Stock
5200
0
D
Non-Qualified Stock Option
59.03
2011-10-14
4
D
0
15000
D
2013-07-30
2019-07-30
Common Stock
15000
0
D
Non-Qualified Stock Option
56.07
2011-10-14
4
D
0
15000
D
2013-12-02
2019-12-02
Common Stock
15000
0
D
Incentive Stock Option
63.11
2011-10-14
4
D
0
6336
D
2014-12-16
2020-12-16
Common Stock
6336
0
D
Non-Qualified Stock Option
63.11
2011-10-14
4
D
0
43664
D
2014-12-16
2020-12-16
Common Stock
43664
0
D
Common Stock was converted pursuant to the Agreement and Plan of Merger, dated as of May 1, 2011, among Teva Pharmaceutical Industries Ltd., Copper Acquisition Corp. and Cephalon, Inc. (the "Merger Agreement") into the right to receive the Merger Consideration (as defined in the Merger Agreement) of $81.50 per share in cash.
Includes 19,950 shares of Restricted Stock with certain vesting restrictions, which restrictions lapsed under the terms of the Merger Agreement at the Effective Time of the Merger.
Options were canceled at the Effective Time of the Merger pursuant to the terms of the Merger Agreement in exchange for a cash payment for each share subject to the option equal to the difference between the Merger Consideration of $81.50 per share and the exercise price of the option.
Reflects four-year anniversary from date of grant. Options vest 25% on each anniversary of grant and expire ten years from date of grant.
Carolyn S. Iosca, Attorney-in-Fact For: Alain Aragues
2011-10-17